Venture Life to sell CDMO business and non-core products in €62 million deal
LONDON: Venture Life Group (AIM: VLG), a leading player in consumer healthcare innovation, has entered into a binding agreement with Italy-based contract development and manufacturing organization (CDMO) BioDue S.p.A. for the sale of its CDMO business and certain non-core products. Under the agreement, BioDue—a portfolio company of The Riverside Group—will acquire 100% of the issued…